This inventor holds 1 USPTO granted patent and 1 published patent application, plus 2 CIPO patents and 3 EPO patents. Top assignee: Genzyme Corporation. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Geoffrey Y Akita: Innovator in Myocardial Infarction Treatment
Introduction
Geoffrey Y Akita is a notable inventor based in Northborough, MA (US). He has made significant contributions to the field of medical treatment, particularly in addressing myocardial infarction. His innovative approach has the potential to improve patient outcomes during critical health events.
Latest Patents
Geoffrey Y Akita holds a patent for the "Treatment of myocardial infarction using TGF-β antagonists." This patent discloses a method for treating patients suffering from myocardial infarction, especially during the acute stage. The method involves administering an antagonist of TGF-β to mitigate adverse consequences associated with myocardial infarction.
Career Highlights
Geoffrey Y Akita is associated with Genzyme Corporation, where he applies his expertise in medical innovations. His work focuses on developing treatments that can significantly impact patient care and recovery.
Collaborations
One of his notable coworkers is Richard C Gregory, with whom he collaborates on various projects within the company.
Conclusion
Geoffrey Y Akita's contributions to the treatment of myocardial infarction exemplify the importance of innovation in healthcare. His work continues to pave the way for advancements in medical treatments that can save lives.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile